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Résumé en
anglais
INTRODUCTION: There is uncertainty as to whether the Guillain-Barré syndrome
(GBS) subtypes, acute inflammatory demyelinating polyradiculoneuropathy (AIDP)
and acute motor axonal neuropathy (AMAN), can be diagnosed
electrophysiologically.
METHODS: We prospectively included 58 GBS patients. Electrodiagnostic testing
(EDX) was performed at means of 5 and 33 days after disease onset. Two
traditional and one recent criteria sets were used to classify studies as
demyelinating or axonal. Results were correlated with anti-ganglioside antibodies
and reversible conduction failure (RCF).
RESULTS: No classification shifts were observed, but more patients were classified
as axonal with recent criteria. RCF and anti-ganglioside antibodies were present in
both subtypes, more frequently in the axonal subtype.
DISCUSSION: Serial EDX has no effect on GBS subtype proportions. The absence
of exclusive correlation with RCF and anti-ganglioside antibodies may challenge the
concept of demyelinating and axonal GBS subtypes based upon electrophysiological
criteria. Frequent RCF indicates that nodal/paranodal alterations may represent
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